ATE79031T1 - Verwendung von ketonderivaten zur behandlung von depressionen. - Google Patents
Verwendung von ketonderivaten zur behandlung von depressionen.Info
- Publication number
- ATE79031T1 ATE79031T1 AT87311082T AT87311082T ATE79031T1 AT E79031 T1 ATE79031 T1 AT E79031T1 AT 87311082 T AT87311082 T AT 87311082T AT 87311082 T AT87311082 T AT 87311082T AT E79031 T1 ATE79031 T1 AT E79031T1
- Authority
- AT
- Austria
- Prior art keywords
- ketone derivatives
- treat depression
- methyl
- depression
- treat
- Prior art date
Links
- 150000002576 ketones Chemical class 0.000 title 1
- -1 2-methyl-1H-imidazol-1-yl Chemical group 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Emergency Protection Circuit Devices (AREA)
- Connection Of Batteries Or Terminals (AREA)
- Electrotherapy Devices (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868630071A GB8630071D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
| EP87311082A EP0276559B1 (de) | 1986-12-17 | 1987-12-16 | Verwendung von Ketonderivaten zur Behandlung von Depressionen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE79031T1 true ATE79031T1 (de) | 1992-08-15 |
Family
ID=10609112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87311082T ATE79031T1 (de) | 1986-12-17 | 1987-12-16 | Verwendung von ketonderivaten zur behandlung von depressionen. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4835173A (de) |
| EP (1) | EP0276559B1 (de) |
| JP (1) | JP2732844B2 (de) |
| KR (1) | KR880007073A (de) |
| AT (1) | ATE79031T1 (de) |
| AU (1) | AU608794B2 (de) |
| CY (1) | CY1693A (de) |
| DE (1) | DE3780940T2 (de) |
| DK (1) | DK662787A (de) |
| ES (1) | ES2051754T3 (de) |
| GB (1) | GB8630071D0 (de) |
| GR (1) | GR3005682T3 (de) |
| HK (1) | HK36593A (de) |
| IE (1) | IE60135B1 (de) |
| IL (1) | IL84844A0 (de) |
| NZ (1) | NZ222949A (de) |
| PH (1) | PH25503A (de) |
| ZA (1) | ZA879458B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5246941A (en) * | 1986-12-17 | 1993-09-21 | Glaxo Group Limited | Method for the treatment of depression |
| JPS63277622A (ja) * | 1986-12-17 | 1988-11-15 | グラクソ、グループ、リミテッド | 医薬 |
| GB8820653D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
| US5221687A (en) * | 1988-09-01 | 1993-06-22 | Glaxo Group Limited | Medicaments |
| US5180728A (en) * | 1989-09-25 | 1993-01-19 | Fujisawa Pharmaceutical Company, Ltd. | Pyrimidoindole derivatives and processes for preparation thereof |
| US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
| EP0591434A4 (en) * | 1991-06-26 | 1994-09-14 | Sepracor Inc | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| EP1181015A2 (de) | 1999-03-01 | 2002-02-27 | Sepracor Inc. | Verfahren zur behandlung von apnoe und apnoe-erkrankungen mit optisch reinem r(+)ondansetron |
| CN1498216A (zh) * | 2000-10-30 | 2004-05-19 | ������ҩ��ҵ����˾ | 新的奥丹西隆盐酸盐晶体和溶剂化物及其制备方法 |
| EP1207160A1 (de) * | 2000-11-20 | 2002-05-22 | Hanmi Pharm. Co., Ltd. | Verfahren zur Herstellung von 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
| KR20070054749A (ko) * | 2001-01-11 | 2007-05-29 | 테바 파마슈티컬 인더스트리즈 리미티드 | 순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법 |
| US20020115707A1 (en) * | 2001-01-11 | 2002-08-22 | Rami Lidor-Hadas | Process for preparing pure ondansetron hydrochloride dihydrate |
| DE60314400T2 (de) * | 2002-04-29 | 2008-02-07 | Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag | Verfahren zur herstellung von 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-on |
| HRP20041136A2 (en) * | 2002-04-30 | 2005-04-30 | Teva Gy�gyszergy�r R�szv�nyt�rsas�g | Novel crystal forms of ondansetron, processes fortheir preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them |
| US20050131045A1 (en) * | 2002-04-30 | 2005-06-16 | Judith Aronhime | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
| HU225885B1 (en) * | 2002-10-17 | 2007-11-28 | Richter Gedeon Nyrt | Process for producing ondansetron hydrochlorid dihydrate of high purity |
| US20110034442A1 (en) * | 2007-08-08 | 2011-02-10 | Jaun Jose Legarda Ibanez | Use and Methods of Use for an Antagonist of the Serotin3 Receptor (5-HT3) and a Selective Modulator of Chloride Channels for the Treatment of Addiction to or Dependence on Medicines/Drugs or Nervous System Disorders |
| AU2019290925B9 (en) * | 2018-06-21 | 2025-08-21 | Societe Des Produits Nestle S.A. | Compositions and methods using a nicotinamide adenine dinucleotide (NAD+) precursor and at least one ketone or ketone precursor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN158970B (de) * | 1981-06-09 | 1987-02-28 | Ici Plc | |
| LU85743A1 (fr) * | 1984-01-25 | 1986-08-04 | Glaxo Group Ltd | Composes heterocycliques |
| GB8401888D0 (en) * | 1984-01-25 | 1984-02-29 | Glaxo Group Ltd | Heterocyclic compounds |
| DE385517T1 (de) * | 1985-03-14 | 1991-07-25 | Beecham Group p.l.c., Brentford, Middlesex | Arzneimittel zur behandlung von erbrechen. |
| GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
| GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
| NL8701682A (nl) * | 1986-07-30 | 1988-02-16 | Sandoz Ag | Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten. |
-
1986
- 1986-12-17 GB GB868630071A patent/GB8630071D0/en active Pending
-
1987
- 1987-12-16 US US07/133,887 patent/US4835173A/en not_active Expired - Lifetime
- 1987-12-16 IE IE341587A patent/IE60135B1/en not_active IP Right Cessation
- 1987-12-16 JP JP62318455A patent/JP2732844B2/ja not_active Expired - Lifetime
- 1987-12-16 DE DE8787311082T patent/DE3780940T2/de not_active Expired - Lifetime
- 1987-12-16 AT AT87311082T patent/ATE79031T1/de not_active IP Right Cessation
- 1987-12-16 NZ NZ222949A patent/NZ222949A/en unknown
- 1987-12-16 AU AU82617/87A patent/AU608794B2/en not_active Ceased
- 1987-12-16 EP EP87311082A patent/EP0276559B1/de not_active Expired - Lifetime
- 1987-12-16 IL IL84844A patent/IL84844A0/xx not_active IP Right Cessation
- 1987-12-16 PH PH36241A patent/PH25503A/en unknown
- 1987-12-16 ES ES87311082T patent/ES2051754T3/es not_active Expired - Lifetime
- 1987-12-16 DK DK662787A patent/DK662787A/da not_active Application Discontinuation
- 1987-12-17 KR KR870014390A patent/KR880007073A/ko not_active Ceased
- 1987-12-17 ZA ZA879458A patent/ZA879458B/xx unknown
-
1992
- 1992-09-10 GR GR920402010T patent/GR3005682T3/el unknown
-
1993
- 1993-04-15 HK HK365/93A patent/HK36593A/en not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY169394A patent/CY1693A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0276559A3 (en) | 1989-10-18 |
| ES2051754T3 (es) | 1994-07-01 |
| IE60135B1 (en) | 1994-06-01 |
| GB8630071D0 (en) | 1987-01-28 |
| AU608794B2 (en) | 1991-04-18 |
| EP0276559A2 (de) | 1988-08-03 |
| GR3005682T3 (de) | 1993-06-07 |
| PH25503A (en) | 1991-07-24 |
| KR880007073A (ko) | 1988-08-26 |
| HK36593A (en) | 1993-04-23 |
| JP2732844B2 (ja) | 1998-03-30 |
| NZ222949A (en) | 1997-06-24 |
| IE873415L (en) | 1988-06-17 |
| DK662787D0 (da) | 1987-12-16 |
| JPS63165314A (ja) | 1988-07-08 |
| DE3780940T2 (de) | 1992-12-24 |
| US4835173A (en) | 1989-05-30 |
| ZA879458B (en) | 1988-11-30 |
| IL84844A0 (en) | 1988-06-30 |
| AU8261787A (en) | 1988-06-23 |
| CY1693A (en) | 1994-01-14 |
| EP0276559B1 (de) | 1992-08-05 |
| DK662787A (da) | 1988-06-18 |
| DE3780940D1 (de) | 1992-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE79031T1 (de) | Verwendung von ketonderivaten zur behandlung von depressionen. | |
| SE8503680L (sv) | Indolderivat | |
| DE3856594D1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
| DE69022249D1 (de) | Knochenwachsapplikator zur Behandlung von Knochengewebe. | |
| DE69521620D1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
| DE69431056D1 (de) | Substituierte oxazolyl-derivate zur behandlung von entzündungen | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| NO873695D0 (no) | Dentalt implantat av skruetypen og fremgangsmaate for bruk av samme. | |
| DE3784693D1 (de) | Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen. | |
| DE69431199D1 (de) | Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen | |
| NO991734L (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
| ATE96317T1 (de) | Verwendung von 5-(subst. phenyl)oxazolidinonderivaten zur behandlung von depressionen. | |
| ATE70181T1 (de) | Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie. | |
| ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
| NO972450L (no) | Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav | |
| FR2676622B1 (fr) | Prothese capillaire et procede de traitement des calvities au moyen de cette prothese. | |
| ATE195072T1 (de) | Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen | |
| DE69113773D1 (de) | Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma. | |
| ATE136463T1 (de) | Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen | |
| DE69022027D1 (de) | 2-Alkyl-3-benzoylbenzofurane zur Behandlung von Herzarrhythmia. | |
| ATE91234T1 (de) | Verwendung von dimetylheptylphenylbutanoylethanolamin bei der behandlung von hyperuricemie. | |
| ATE299021T1 (de) | Verwendung von oxazolidinonderivaten zur behandlung von psoriasis | |
| DE68906028D1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
| DE68914886D1 (de) | Mittel zur Behandlung von Raynaud's Krankheit. | |
| ATE136776T1 (de) | Verwendung von heptastigmin zur behandlung der zerebralen ictus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |